Skip to main content

Posts

Showing posts from June, 2020

Yes!! Grumbletonians need to know if lock down was successful?

Excerpts, aspects and perspectives from different news agencies discussing how the Indian lockdown worked out to be a total disaster.   India's Hurried Decision to Impose Nationwide lockdown was ill-planned & worst conceived! Alluding to the Hindu epic, Ramayana, the Prime Minister said, “For 21 days, forget what is stepping outside. (Imagine) there is a Lakshman Rekha on your doorstep.” Modi would later allude to another Hindu epic, Mahabharata, in equating the challenge of the 21-day initial lockdown to the 18-day battle. Barely four hours after his announcement on March 24, at the stroke of the midnight hour, when the world slept, India went into its first coronavirus-induced lockdown. And 68 days, 1,73,763 positive cases and 4,971 deaths later, on May 31, the ministry of home affairs issued an order announcing a phased reopening or ‘Unlock 1’ by dint of which almost all prohibitory orders were lifted, except in containment zones. In the preceding 24 hours, there have b...

How to catch #Covid19? Here are the ways of growing agreement!

Three months into the coronavirus crisis in India, there’s a growing consensus about a central question: How do people become infected? Getting the Covid-19 virus involves three steps: 1 Coughing, talking and breathing creates virus-carrying droplets of various sizes. 2 Enough virus has to make itself over to you or build up around you over time to trigger an infection. 3 The virus has to make its way into your respiratory tract and use the ACE-2 receptors there to enter cells and replicate. It’s not common to contract Covid-19 from a contaminated surface, scientists say. And fleeting encounters with people outdoors are unlikely to spread the coronavirus. Instead, the major culprit is close-up, person-to-person interactions for extended periods. Crowded events, poorly ventilated areas and places where people are talking loudly—or singing, in one famous case—maximize the risk. Stressing physical distancing and masks, and reducing the number of gatherings in enclosed spaces. “We should n...

"If you are experiencing violence during COVID-19, know what you need to do!" - Hasrat Ullah Sherwani

Source: Who.Int Violence During Covid-19 - Make a safety plan for you and your children: If you are experiencing violence at home and need to leave in a hurry Identify a friend, neighbor, relative, or shelter you can go to Plan how to get there Keep ready essential personal items to take with you #आरक्षण_बेबुनियाद_है, #Brahmin_Regiment, #ThursdayThoughts, #कोलेजियम_सिस्टम_कलंक_है, #LaluPrasadYadav. #SaveReservation, #आरक्षण_बेबुनियाद_है, #कोलेजियम_सिस्टम_कलंक_है, #WeAreBulletproofTheEternal, #ReleaseSafooraZargar.  ## hasratullahsherwani.blogspot.com #HasratUllahSherwani #HasratSherwani #HUS #GoHUS #SamajwadiParty

Parenting in the time of COVID-19 from Hasrat Ullah Sherwani

Hasrat Ullah Sherwani - Parenting in the midst of Covid-19   To help parents interact constructively with their children during this time of confinement, these one-page tips for parents cover planning 1-on-1 time, staying positive, creating a daily routine, avoiding bad behavior, managing stress, and talking about COVID-19. Use them to your and your kids’ advantage, and have fun in doing so. COVID-19 PARENTING: One-on-One Time Set aside time to spend with each child It can be for just 20 minutes, or longer - it's up to us. It can be at the same time each day so children or teenagers can look forward to it. ##  http://www.hasratullahsherwani.com/ #SaveDalitInUP, #KanganaRanaut, #रक्षा_मंत्री_जवाब_दो, #HealthOverExams, #PakPanics. #OppositionNeKyaKiya, #BiharKaCmGayabHai, #MissYouYuvi, #IndiaFirstAlways, #रक्षा_मंत्री_जवाब_दो. #HasratUllahSherwani #HasratSherwani #HUS #GoHUS #SamajwadiParty

India Approves Emergency Use Of Remdesivir To Treat COVID patients

Remdesivir - First drug to show improvement in COVID patients in formal clinical trials Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials. It was granted emergency use authorization by the US Food and Drug Administration last month and has received approval by Japanese health regulators. Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2. Of the 61 patients who received at least one dose of remdesivir, data from 8 could not be analyzed (including 7 patients with no post-treatment data and 1 with a dosing error). Of the 53 patients whose data were analyzed, 22 were in the United States, 22 in Europe or Canada, and 9 in Japan. At baseline, 30 patients (57%) were receiving mechanical ventilation and 4 (8%) were receiving extracorporeal membrane oxygenation.  Remdesivir To Treat COVID patients During a median follow-up of 18 days, 36 patients (68%) had an improvement...